This inventor holds 3 USPTO granted patents. Top assignees: Washington University, University of Pittsburgh. Active years: 2020-2022.
Location History:
- St. Louis, MO (US) (2020)
- Richmond Heights, MO (US) (2020 - 2022)
Company Filing History:
3 out of 1,374 
2 out of 1,955 
Years Active: 2020-2022
Title: Hiroko Yano: Innovator in Neurodegenerative Disorder Research
Introduction
Hiroko Yano is a prominent inventor based in Richmond Heights, MO (US). She has made significant contributions to the field of neurodegenerative disorders, particularly in relation to Huntington's Disease. With a total of 3 patents, her work focuses on innovative methods to combat neurodegeneration.
Latest Patents
Yano's latest patents include groundbreaking inventions aimed at addressing neurodegenerative conditions. One of her notable patents is related to "Mutant huntingtin-mediated protein dysfunction." This invention outlines methods for inhibiting neurodegeneration in individuals suffering from or genetically predisposed to Huntington's Disease by enhancing the activity of the TIM23 mitochondrial protein import complex in neurons. Another significant patent involves "Methods of treating neurodegenerative disorders comprising DNA methyltransferase inhibitors." This disclosure presents a method for treating neurodegenerative disorders through the administration of DNA methyltransferase inhibitors.
Career Highlights
Throughout her career, Hiroko Yano has worked with esteemed institutions such as Washington University and the University of Pittsburgh. Her research has been pivotal in advancing our understanding of neurodegenerative diseases and developing potential treatments.
Collaborations
Yano has collaborated with notable colleagues, including Robert Friedlander and Albert Kim. These partnerships have further enriched her research and contributed to her innovative work in the field.
Conclusion
Hiroko Yano's contributions to neurodegenerative disorder research exemplify her dedication to innovation and improving patient outcomes. Her patents reflect a commitment to finding effective treatments for challenging conditions like Huntington's Disease.